Connected care enters a vital security frontier

Tern plc

As hospitals deploy more connected devices, the real vulnerability is no longer the network but the devices themselves. Device Authority is targeting this exact gap, offering a way to manage trust, identity and compliance at scale, all without manual oversight.

At the heart of the offering is automation of device trust and lifecycle management. For manufacturers and operators of connected medical equipment, the challenge lies in provisioning, rotating, revoking and monitoring credentials across large fleets, often in highly regulated settings. The KeyScaler platform is branded as delivering exactly that: seamless device registration, certificate management, enforcing Zero Trust policy at the edge, and continuous assurance of connected devices. By automating those security operations, the firm aims to reduce human error, accelerate incident response and support compliance across healthcare networks.

The company’s positioning in IoMT complements its broader IoT/OT play, suggesting opportunity for cross‑industry efficiencies. With connected medical devices trending upwards, and hospital networks under increasing pressure to secure them against threat actors and compliance breaches, the addressable market is set to expand.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern notes automotive momentum at Device Authority

Tern Plc notes that Device Authority, in which it holds a 25.3% stake, has announced further progress in the automotive sector, securing a new OEM customer and expanding an existing Tier 1 deployment.

Key management emerges as a delivery risk in automotive software

Key management is becoming a delivery-critical constraint in software-defined vehicles, influencing risk, compliance and programme scalability.

Pharma teams gain early insight into message effectiveness

Talking Medicines gives pharma teams early insight into which messages resonate with healthcare professionals.

Talking Medicines joins 2026 UK AI Index

Talking Medicines joins the UK AI Index 2026, confirming its growing role in data-driven healthcare strategy.

AI in Healthcare 2025

In 2025, AI began reshaping healthcare delivery and marketing with practical applications, signalling a maturing investment landscape.

Talking Medicines targets messaging risk in pharma brand strategy

Talking Medicines reduces messaging risk for pharma brands by measuring real-time HCP response.

Search

Search